10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
AMGEN INC | ||
Ticker: AMGN Fiscal Year: 2022 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2022 10-K (Filed: Feb 9, 2023) | ||
(In Millions, except shares in actual) | ||
As of | As of | |
Dec 31, 2022 | Dec 31, 2021 | |
ASSETS | ||
Current assets: | ||
Cash and cash equivalents | $ 7,629 | 7,989 |
Marketable securities | 1,676 | 48 |
Trade receivables, net | 5,563 | 4,895 |
Inventories | 4,930 | 4,086 |
Other current assets | 2,388 | 2,367 |
Total current assets | 22,186 | 19,385 |
Property, plant and equipment, net | 5,427 | 5,184 |
Intangible assets, net | 16,080 | 15,182 |
Goodwill | 15,529 | 14,890 |
Other noncurrent assets | 5,899 | 6,524 |
Total assets | 65,121 | 61,165 |
LIABILITIES AND STOCKHOLDERS EQUITY | ||
Current liabilities: | ||
Accounts payable | 1,572 | 1,366 |
Accrued liabilities | 12,524 | 10,731 |
Current portion of long-term debt | 1,591 | 87 |
Total current liabilities | 15,687 | 12,184 |
Long-term debt | 37,354 | 33,222 |
Long-term tax liabilities | 5,757 | 6,594 |
Other noncurrent liabilities | 2,662 | 2,465 |
Contingencies and commitments | ||
Stockholders equity: | ||
Common stock and additional paid-in capital; $0.0001 par value per share; 2,750.0 shares authorized; outstanding534.0 shares in 2022 and 558.3 shares in 2021 | 32,514 | 32,096 |
Accumulated deficit | (28,622) | (24,600) |
Accumulated other comprehensive loss | (231) | (796) |
Total stockholders equity | 3,661 | 6,700 |
Total liabilities and stockholders equity | 65,121 | 61,165 |
External Links | |
AMGEN INC (AMGN) Fiscal Year 2022 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |